ARCHITECT Methotrexate Controls - SFDA Registration ME0000002987SFDAA00025
Access comprehensive regulatory information for ARCHITECT Methotrexate Controls in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000002987SFDAA00025 and manufactured by Abbott GmbH. and Co. KG.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
For the quantitative determination of methotrexate in human serum and plasma
The ARCHITECT Methotrexate Low, Medium, and High Controls are for the estimation of test precision and the detection of systematic analytical deviations of the ARCHITECT i System when used for the quantitative determination of methotrexate in human serum and plasma. ARCHITECT Methotrexate Control X is used to provide assurance of accuracy when performing manual sample dilutions.
[]